Dr. Xianggao Zhu 朱向高
Chief Physician
Department of Radiation Oncology, Peking University Cancer Hospital, Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Precision intensity-modulated radiotherapy for hepatobiliary, pancreatic, lymphoma, prostate, and rectal cancers. Stereotactic body radiotherapy (SBRT) and comprehensive treatment for liver metastases.
Dr. Zhu studied oncology at Peking University Health Science Center starting in 2004. With over 20 years of clinical radiotherapy experience, Dr. Zhu previously worked at Peking University People’s Hospital and Peking University Cancer Hospital. Since February 2023, Dr. Zhu has supported the National Regional Medical Center, serving as Academic Director of the Radiotherapy Center at Peking University Cancer Hospital Inner Mongolia Hospital. Since November 2024, Dr. Zhu has served as Deputy Director of the Radiotherapy Department there, managing clinical care for abdominal and pelvic tumors.
Professional roles
- Member, Youth Committee, Radiation Oncology Branch, Chinese Medical Doctor Association
- Member, Youth Committee, Colorectal Tumor Professional Committee, Chinese Medical Doctor Association
- Member, Hepatobiliary and Pancreatic Professional Committee, Beijing Anti-Cancer Association
- Youth Editorial Board Member, Journal of Liver Cancer (Electronic Edition)
Name order: in Chinese the family name comes first (Zhu Xianggao). Papers usually list the name as Xianggao Zhu or Zhu X.
Selected publications
49 papers on PubMed matched by name and affiliation; 4 as first or senior author since 2016. Most recent first- or senior-author papers:
- MedComm (2020), 2026 (senior author): Hepatocellular Carcinoma Targeted Thermosensitive Cu(2+) Liposomes Based on the Cuproptosis Mechanism. PubMed 42871366
- Heliyon, 2024 (first author): lncRNA SNHG1 promotes the progression of hepatocellular carcinoma by regulating the miR-7-5p/IGF2BP2 axis. PubMed 38545199
- Am J Clin Oncol, 2017 (first author): Two-week Course of Preoperative Radiotherapy for Locally Advanced Rectal Adenocarcinoma: 8 Years' Experience in a Single Institute. PubMed 25503430
- Am J Transl Res, 2016 (first author): Intensity-modulated radiation therapy for pelvic oligo-recurrence from rectal cancer: long-term results from a single institution. PubMed 27158413
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion